Advanced AI Algorithm Enhances Heart Attack Risk Prediction

A novel AI algorithm developed by researchers at UWA offers a more accurate and comprehensive way to predict heart attack risk, outperforming traditional calcium scoring methods and paving the way for personalized cardiac care.
Researchers from the University of Western Australia, in collaboration with industry partner Artrya, have developed a revolutionary fully automated AI algorithm that significantly outperforms existing methods in predicting the risk of heart attacks. The study, published in the journal Circulation: Cardiovascular Imaging, introduces the CAC-DAD score, an innovative tool that measures coronary calcification burden, assesses the distance of each plaque from the artery origin, and reclassifies dense plaques as lower risk—all with a single click.
Dr. Gavin Huangfu, the lead author and a specialist at UWA's Medical School and the Harry Perkins Institute of Medical Research, explained that while coronary calcium scoring has transformed heart disease prevention in asymptomatic individuals, it has notable limitations. Traditional scoring methods do not account for plaque location or differentiate dense plaques, which are typically stable and less likely to cause adverse events. The new AI-driven approach analyzes individual plaques, providing a more precise risk assessment.
The CAC-DAD score effectively measures the total calcification and considers the spatial distribution of plaques, allowing for more accurate predictions of cardiac events, especially around surgical procedures. When used alongside the conventional Agatston score, it enhances the predictive accuracy further, opening new avenues for clinical application.
Professor Girish Dwivedi emphasized that heart disease remains the leading cause of death worldwide. He highlighted that accurate risk stratification through tools like the CAC-DAD score is vital for targeted prevention and management. Once validated in larger, diverse cohorts, this scoring system could become a standard component of personalized cardiac care, facilitating early interventions and better patient outcomes.
This advancement underscores the shift toward personalized medicine, where detailed, AI-assisted evaluations supplement traditional risk scores. The research marks a significant step forward in cardiovascular diagnostics, with potential to reduce heart attack incidence and improve survival rates.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Method Tracks Tumor Evolution to Combat Resistant High-Grade Serous Ovarian Cancer
Memorial Sloan Kettering researchers introduce CloneSeq-SV, a cutting-edge method to monitor tumor evolution and resistance in high-grade serous ovarian cancer, opening new avenues for personalized treatment strategies.
Genetic Mutation Linked to Severe Paralysis After Mild Infections in Children
Research has uncovered a genetic mutation in the RCC1 gene that causes severe nerve damage and paralysis in children following mild infections, offering new hope for diagnosis and treatment.
Advancements in Ventilation Modes May Enhance Outcomes for Critically Ill ICU Patients
Recent research suggests that the personalized ventilation mode PAV+ can improve patient experience and safety during mechanical ventilation in the ICU, reducing sedation time and delirium incidence.
Innovative Drug Combo Reduces Alcohol Intake and Nausea in Clinical Study
A groundbreaking clinical trial reveals that combining varenicline and bupropion can significantly lower alcohol cravings and consumption while reducing nausea, promising improved treatment options for alcohol use disorder.